Percutaneous absorption with emphasis on sunscreens

Photochemical and Photobiological Sciences

Volumn 9, Issue 4, 2010, Pages 482-488

  Gonzalez, Helena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951125750     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b9pp00149b     Document Type: Review

References (70)

1. H. Rorsman, A. Björnberg and A. Vahlquist, Dermatologi venereologi, Studentlitteratur AB, Lund, Sweden, 7th Edn, 2007, pp. 1-20 (in Swedish)
2. Rook's textbook of dermatology, ed., T. Burns, S. Breathnach, and, N. Cox, et al., 7th edn, vol. 1, 2004
3. S. Grayson P. M. Elias Isolation and lipid biochemical characterization of stratum corneum membrane complexes: implications for the cutaneous permeability barrier J. Invest. Dermatol. 1982 78 128 35
4. W. Rayner Cyanosis in newly born children caused by aniline marking ink Br. Med. J. 1886 1 294
5. H. Powell O. Swarner L. Gluck et al., Hexachlorophene myelinopathy in premature infants J. Pediatr. 1973 82 976 81
6. G. Martin-Bouyer R. Lebreton M. Toga et al., Outbreak of accidental hexachlorophene poisoning in France Lancet 1982 319 91 5
7. R. C. Wester and H. Maibach, In vivo methods for percutaneous absorption measurement, in Topical absorption of dermatological products, New York, Marcel Dekker, 2002, pp. 145-156
8. M. B. Reddy A. L. Stinchcomb R. H. Guy et al., Determining dermal absorption parameters in vivo from tape strip data Pharm. Res. 2002 19 292 8
9. S. Kezic Methods for measuring in vivo percutaneous absorption in humans Hum. Exp. Toxicol. 2008 27 289 95
10. V. P. Shah IV-IVC for topically applied preparations-a critical evaluation Eur. J. Pharm. Biopharm. 2005 60 309 14
11. C. Herkenne A. Naik Y. N. Kalia et al., Dermatopharmacokinetic prediction of topical drug bioavailability in vivo J. Invest. Dermatol. 2007 127 887 94
12. V. Shah, Topical Dermatological drug product NDAs and ANDAs - in vivo bioavailability, bioequivalence, in vitro release and associated studies, US Food and Drug Administration UDoHaHS, Rockville, 1998
13. E. C. de Lange A. G. de Boer D. D. Breimer Methodological issues in microdialysis sampling for pharmacokinetic studies Adv. Drug Delivery Rev. 2000 45 125 48
14. A. V. Zvyagin X. Zhao A. Gierden et al., Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo J. Biomed. Opt. 2008 13 064031
15. T. J. Franz Percutaneous absorption on the relevance of in vitro data J. Invest. Dermatol. 1975 64 190 5
16. I. Jakasa S. Kezic Evaluation of in vivo animal and in vitro models for prediction of dermal absorption in man Hum. Exp. Toxicol. 2008 27 281 8
17. K. Ackermann S. Lombardi Borgia H. C. Korting et al., The Phenion(R) Full-Thickness Skin Model for Percutaneous Absorption Testing Skin Pharmacol. Physiol. 2010 23 105 12
18. R. L. Bronaugh, H. L. Hood and M. E. K. Kraeling, et al., Determination of percutaneous absorption by in vitro techniques, in Topical absorption of dermatological products, ed., R. L. Bronaugh, and, H. Maibach, Marcel Dekker, Inc., New York, 2002, pp. 157-61
19. R. L. Bronaugh In vitro percutaneous absorption models Ann. N. Y. Acad. Sci. 2000 919 188 91
20. B. Baroli M. G. Ennas F. Loffredo et al., Penetration of metallic nanoparticles in human full-thickness skin J. Invest. Dermatol. 2007 127 1701 12
21. A. Mavon C. Miquel O. Lejeune et al., In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen Skin Pharmacol. Physiol. 2007 20 10 20
22. R. J. Feldmann H. I. Maibach Absorption of some organic compounds through the skin in man J. Invest. Dermatol. 1970 54 399 404
23. A. Arancibia G. Borie E. Cornwell et al., Pharmacokinetic study on the percutaneous absorption of p-aminobenzoic acid from three sunscreen preparations Farmaco [Prat.] 1981 36 357 65
24. R. C. Wester J. Melendres L. Sedik et al., Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo Toxicol. Appl. Pharmacol. 1998 151 159 65
25. L. H. Wang W. S. Huang H. M. Tai Simultaneous determination of p-aminobenzoic acid and its metabolites in the urine of volunteers, treated with p-aminobenzoic acid sunscreen formulation J. Pharm. Biomed. Anal. 2007 43 1430 6
26. H. A. Benson Assessment and clinical implications of absorption of sunscreens across skin Am. J. Clin. Dermatol. 2000 1 217 24
27. C. G. Hayden S. E. Cross C. Anderson et al., Sunscreen penetration of human skin and related keratinocyte toxicity after topical application Skin Pharmacol. Physiol. 2005 18 170 4
28. H. Gustavsson Gonzalez A. Farbrot O. Larko Percutaneous absorption of benzophenone-3, a common component of topical sunscreens Clin. Exp. Dermatol. 2002 27 691 4
29. H. Gonzalez A. Farbrot O. Larko et al., Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation Br. J. Dermatol. 2006 154 337 40
30. C. G. Hayden M. S. Roberts H. A. Benson Systemic absorption of sunscreen after topical application Lancet 1997 350 863 4
31. S. H. Dromgoole H. I. Maibach Sunscreening agent intolerance: contact and photocontact sensitization and contact urticaria J. Am. Acad. Dermatol. 1990 22 1068 78
32. C. S. Okereke A. M. Kadry M. S. Abdel-Rahman et al., Metabolism of benzophenone-3 in rats Drug Metab. Dispos. 1993 21 788 91
33. H. Gonzalez C.-E. Jacobson A. M. Wennberg et al., Solid-phase extraction and reverse-phase HPLC: application to study the urinary excretion pattern of benzophenone-3 and its metabolite 2,4-dihydroxybenzophenone in human urine Anal. Chem. Insights 2008 3 1 7
34. C. P. Strassburg A. Strassburg S. Kneip et al., Developmental aspects of human hepatic drug glucuronidation in young children and adults Gut 2002 50 259 65
35. A. Anderson W. Bergfeld D. Belsito R. Shank C. Klaassen P. Snyder J. Marks T. Slaga CIR, Annual Review of Cosmetic Ingredient Safety Assessments-2002/2003 Int. J. Toxicol. 2005 24 Suppl 1 1 102
36. M. Schlumpf B. Cotton M. Conscience et al., In vitro and in vivo estrogenicity of UV screens Environ. Health Perspect. 2001 109 239 44
37. N. R. Janjua B. Mogensen A. M. Andersson et al., Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl- benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans J. Invest. Dermatol. 2004 123 57 61
38. B. Berne A. M. Ros 7 years experience of photopatch testing with sunscreen allergens in Sweden Contact Dermatitis 1998 38 61 4
39. A. M. Bryden H. Moseley S. H. Ibbotson et al., Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group Br. J. Dermatol. 2006 155 737 47
40. V. K. Gupta J. L. Zatz M. Rerek Percutaneous absorption of sunscreens through micro-yucatan pig skin in vitro Pharm. Res. 1999 16 1602 7
41. F. Benech-Kieffer P. Wegrich R. Schwarzenbach et al., Percutaneous absorption of sunscreens in vitro: interspecies comparison, skin models and reproducibility aspects Skin Pharmacol. Appl. Skin Physiol. 2000 13 324 35
42. E. Chatelain B. Gabard C. Surber Skin penetration and sun protection factor of five UV filters: effect of the vehicle Skin Pharmacol. Appl. Skin Physiol. 2003 16 28 35
43. N. R. Janjua B. Kongshoj A. M. Andersson et al., Sunscreens in human plasma and urine after repeated whole-body topical application J. Eur. Acad. Dermatol. Venereol. 2008 22 456 61
44. E. Touitou B. Godin Skin nonpenetrating sunscreens for cosmetic and pharmaceutical formulations Clin. Dermatol. 2008 26 375 9
45. U. Hagedorn-Leweke B. C. Lippold Absorption of sunscreens and other compounds through human skin in vivo: derivation of a method to predict maximum fluxes Pharm. Res. 1995 12 1354 60
46. U. M. Schauer W. Volkel A. Heusener et al., Kinetics of 3-(4-methylbenzylidene)camphor in rats and humans after dermal application Toxicol. Appl. Pharmacol. 2006 216 339 46
47. H. J. Weigmann J. Lademann S. Schanzer et al., Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability Skin Pharmacol. Appl. Skin Physiol. 2001 14 Suppl 1 98 102
48. S. Simeoni S. Scalia H. A. Benson Influence of cyclodextrins on in vitro human skin absorption of the sunscreen, butyl-methoxydibenzoylmethane Int. J. Pharm. 2004 280 163 71
49. L. Montenegro C. Carbone D. Paolino et al., In vitro skin permeation of sunscreen agents from O/W emulsions Int. J. Cosmet. Sci. 2008 30 57 65
50. K. A. Walters K. R. Brain D. Howes et al., Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro Food Chem. Toxicol. 1997 35 1219 25
51. P. Treffel B. Gabard Skin penetration and sun protection factor of ultra-violet filters from two vehicles Pharm. Res. 1996 13 770 4
52. A. Anderson W. Bergfeld D. Belsito R. Shank C. Klaassen P. Snyder J. Marks T. Slaga CIR, Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate Int. J. Toxicol. 2003 22 Suppl 3 1 108
53. F. Benech-Kieffer W. J. Meuling C. Leclerc et al., Percutaneous absorption of Mexoryl SX in human volunteers: comparison with in vitro data Skin Pharmacol. Appl. Skin Physiol. 2003 16 343 55
54. J. P. Ryman-Rasmussen J. E. Riviere N. A. Monteiro-Riviere Penetration of intact skin by quantum dots with diverse physicochemical properties Toxicol. Sci. 2006 91 159 65
55. M. H. Tan C. A. Commens L. Burnett et al., A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens Australas. J. Dermatol. 1996 37 185 7
56. R. G. van der Molen H. Driller J. M. van't Noordende et al., Determination of the stability of titaniumdioxide particles in a sunscreen after application on the skin J. Invest. Dermatol. 1999 113 703
57. A. O. Gamer E. Leibold B. van Ravenzwaay The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin Toxicol. in Vitro 2006 20 301 7
58. S. E. Cross B. Innes M. S. Roberts et al., Human skin penetration of sunscreen nanoparticles: in vitro assessment of a novel micronized zinc oxide formulation Skin Pharmacol. Physiol. 2007 20 148 54
59. G. J. Nohynek J. Lademann C. Ribaud et al., Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety Crit. Rev. Toxicol. 2007 37 251 77
60. A review of the scientific literature on the safety of nanoparticulate titanium dioxide or zinc oxide in sunscreens, Department of health and ageing, Australia, 2006
61. S. T. Stern S. E. McNeil Nanotechnology safety concerns revisited Toxicol. Sci. 2008 101 4 21
62. F. Pirot J. Millet Y. N. Kalia et al., In vitro study of percutaneous absorption, cutaneous bioavailability and bioequivalence of zinc and copper from five topical formulations Skin Pharmacol 1996 9 259 69
63. A. B. G. Landsdown A. Taylor Zinc and titanium dioxides: promising UV absorbers, but what influence do they have on the intact skin? Int. J. Cosmet. Sci. 1997 19 167 72
64. A. S. Dussert E. Gooris J. Hemmerle Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum Int. J. Cosmet. Sci. 1997 19 119 29
65. J. Lademann H. Weigmann C. Rickmeyer et al., Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice Skin Pharmacol. Appl. Skin Physiol. 1999 12 247 56
66. F. Pflucker V. Wendel H. Hohenberg et al., The human stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide Skin Pharmacol. Appl. Skin Physiol. 2001 14 Suppl 1 92 7
67. J. Schulz H. Hohenberg F. Pflucker et al., Distribution of sunscreens on skin Adv. Drug Delivery Rev. 2002 54 Suppl 1 S157 63
68. S. Gottbrach C. C. Mueller-Goymann Penetration and visualisation of titanium dioxide microparticles in human stratum corneum - effect of different formulations on the penetration of titanium dioxide Cosmetics 2003 129 11 7
69. E. Gontier C. Habchi T. Pouthier et al., Nuclear microscopy and electron microscopy studies of percutaneous penetration of nanoparticles in mammalian skin J. Invest. Dermatol. 2004 123 A11
70. F. Menzel T. Reinert J. Vogt et al., Investigations of percutaneous uptake of ultrafine TiO2 particles at the high energy ion nanoprobe LIPSION Nucl. Instrum. Methods Phys. Res., Sect. B 2004 219-220 82 6